详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Chinese Guideline on allergen immunotherapy for allergic rhinitis

7| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Pediatric Respiratory Medicine, Pubin Children Hospital, Shanghai Children Medical Center Affiliated to Shanghai Jiao TongUniversity School of Medicine, Shanghai 200092, China [2]Department of Otorhinolaryngology, Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan 430022, China [3]Department of Otorhinolaryngology, the First Affiliated Hospital,Nanjing Medical University, Nanjing 210029, China [4]International Centre for Allergy Research, Nanjing Medical University, Nanjing 210029,China [5]Department of Allergy & Immunology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China [6]Department of Otorhinolaryngology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China [7]Department ofAllergy, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China [8]Department of Otolaryngology, Head andNeck Surgery, Affiliated Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai 200031, China [9]State Key Laboratory of RespiratoryDisease, Allergy and Clinical Immunology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China [10]Departmentof otolaryngology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China [11]The PLA Center of respiratory and allergicdisease diagnosing and management, Shenyang 110016, China [12]Department of Otolaryngology, West China Hospital, Sichuan University,Chengdu 610041, China [13]Department of Otolaryngology Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong Universityof Science and Technology, Wuhan 430030, China [14]Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, CapitalMedical University, Beijing 100730, China [15]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China [16]Department of Otorhinolaryngology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China [17]Department of PediatricRespiratory Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, China [18]Department of Pulmonary and Critical Care Medicine, Shanghai Ruijin Hospital affiliated to Shanghai Jiaotong University, School of Medicine,Shanghai 200025, China [19]Department of Otolaryngology, Renmin Hospital of Wuhan University, Wuhan 430060, China [20]Department of Allergy,NO.202 Hospital of PLA, Shenyang 110003, China [21]Department of Allergy, Beijing Children’s Hospital, Capital Medical University, NationalCenter for Children’s Health, Beijing 100045, China [22]Department of Respiratory Medicine, the General Hospital of Shenyang Military Region,Shenyang 110016, China [23]Department of Otolaryngology Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630, China [24]Scientific Affairs, ALK, Guangzhou 510300, China [25]Department of Allergy, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100720, China [26]Department of Allergy, Beijing TongRenHospital, Capital Medical University, Beijing 100730, China

出处：

DOI：

ISSN：

关键词： Allergen immunotherapy (AIT) allergic rhinitis (AR) guideline China

摘要：

The present document is based on a consensus reached by a panel of experts from Chinese Society of Allergy (CSA) and Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G). Allergen immunotherapy (AIT), has increasingly been used as a treatment for allergic rhinitis (AR) globally, as it has been shown to provide a long-term effect in improving nasal and ocular symptoms, reducing medication need, and improving quality of life. AIT is currently the only curative intervention that can potentially modify the immune system in individuals suffering from AR and prevent the development of new sensitization and the progression of disease from AR to asthma. Although the use of AIT is becoming more acceptable in China, to date no AR immunotherapy guideline from China is available for use by the international community. This document has thus been produced and covers the main aspects of AIT undertaken in China; including selection of patients for AIT, the allergen extracts available on the Chinese market, schedules and doses of allergen employed in different routes of AIT, assessment of effect and safety, patients' administration and follow-up, and management of adverse reactions. The Chinese guideline for AR immunotherapy will thus serve as a reference point by doctors, healthcare professionals and organizations involved in the AIT of AR in China. Moreover, this guideline will serve as a source of information for the international community on AIT treatment strategies employed in China.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2016]版：

大类 | 4 区医学

小类 | 4 区呼吸系统

最新[2025]版：

大类 | 4 区医学

小类 | 4 区呼吸系统

JCR分区：

出版当年[2015]版：

Q3 RESPIRATORY SYSTEM

最新[2024]版：

Q3 RESPIRATORY SYSTEM

影响因子： 1.9 最新[2024版] 2.5 最新五年平均 1.649 出版当年[2015版] 0 出版当年五年平均 1.783 出版前一年[2014版] 2.365 出版后一年[2016版]

第一作者：

第一作者机构： [1]Department of Pediatric Respiratory Medicine, Pubin Children Hospital, Shanghai Children Medical Center Affiliated to Shanghai Jiao TongUniversity School of Medicine, Shanghai 200092, China

共同第一作者：

通讯作者：

通讯机构： [14]Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, CapitalMedical University, Beijing 100730, China [15]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China [26]Department of Allergy, Beijing TongRenHospital, Capital Medical University, Beijing 100730, China [*1]Beijing Institute of Otolaryngology, No. 17, HouGouHuTong, DongCheng District, Beijing 100005, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Chinese Guideline on allergen immunotherapy for allergic rhinitis

文献详情

相关文献